MOORE ANNA enters TRANSCODE THERAPEUTICS, INC. with 1.55M shares plus derivative instruments
Holding both equity and derivatives at entry signals strong long-term conviction in the company.
Direct Derivatives
Filed: 7/8/2021ACC: 0001104659-21-090400
1.55M
Baseline shares
100% direct
1.55M
Direct ownership
1 position
60.66K
Derivative underlying
1 instrument
1
Security positions
All direct
Non-Derivative Holdings1
Common Stock
DirectShares owned1.55M
Total
1.55M direct1.55M
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 1.55M | Direct |
| Total | 1.55M | 1.55M direct |
Derivative Holdings1
Stock Option (Right to Buy)
DirectUnderlying security
Common Stock
Underlying shares
60.66K
Shares owned
N/A
Exercise price
0.091
Expiration
—
Exercise window
—
Total
Underlying
60.66K
Owned
0.00
| Security | Underlying | Exercise Price | Exercise Window | Expiration | Underlying Shares | Shares Owned |
|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Common Stock | 0.091 | — | — | 60.66K | N/A |
| Total | 60.66K | 0.00 | ||||